QRDA Incidence Report FEMALE-B MEASURE-ONE World VistA Test Clinic WorldVistA Test Clinic Dr. Nancy Anthracite 123 Maple Ave Gaithersburg MD 20877 Nancy Anthracite MD 123 Maple Ave Gaithersburg MD 20877 Nancy Anthracite MD
Measure set: CMS EHR Measure Set 2010 Measures Set Measures
Measure Section CMS Measure #1: Diabetes Mellitus: Hemoglobin A1c Poor Control in Diabetes Mellitus CMS Measure #2: Diabetes Mellitus: Low Density Lipoprotein (LDL-C) Control in Diabetes Mellitus CMS Measure #3: Diabetes Mellitus: High Blood Pressure Control in Diabetes Mellitus CMS Measure #5: Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) CMS Measure #110: Preventive Care and Screening: Influenza Immunization for Patients >= 50 Years CMS Measure #111: Preventive Care and Screening: Pneumonia Vaccination for Patients 65 Years and Older CMS Measure #112: Preventive Care and Screening: Screening Mammography CMS Measure #113: Preventive Care and Screening: Colorectal Cancer Screening CMS Measure #124: Health Information Technology (HIT): Adoption/Use of Electronic Health Records (EHR) CMS Measure eRx:Adoption/Use of Medication Electronic Prescribing Measure Percentage of patients 18 through 75 years with diabetes mellitus who had most recent hemoglobin A1C greater than 9.0% Percentage of patients 18 through 75 years with diabetes mellitus who had most recent LDL-C level in control (less than 100 mg./dL) Percentage of patients 18 through 75 years with diabetes mellitus who had most recent blood pressure in control (less than 140/80 mmHg) Percentage of patients 18 years and older with a diagnosis of heart frilure and LVSD who were prescribed ACE inhibitor or ARB therapy Percentage of patients 18 aged 18 years and older wit a diagnosis of CAD and prior MI who were prescribed beta-blocker therapy Percentage of patients aged 50 years and older who received an influenza immunization during the flu season (September through February) Percentage of patients afed 65 years and older who have ever received a pneumoccal vaccine Percentage of womaen aged 40 through 69 years who had a mammogram to screen for breast cancer within 24 months Percentage of patients aged 50 through 80 who received the appropriate colorectal cancer screening Documents whether provider has adopted and is using health information technology. To qualify, the provider must havea adopted and be using a certified/qualified electronic health record (EHR) Documents whether provider has adopted and is using ePrescribing
Reporting Parameters Reporting Period Jan 1, 2010 to Dec 31, 2010
Purpose CEND PHR
Problems
Type Date Code Description Status Source
Problem
Oct 13, 2010
250.00 (ICD9CM) Diabetes Mellitus without mention of Complication, type II or unspecified type, Active EIGHT PROVIDER Scholar Extraordinaire
Problem
Oct 5, 2010
848.9 (ICD9CM) Sprains (ICD-9-CM 848.9) Active MATTHEW M KING
VA MEDICAL CENTER ALBANY NY 12180 Scholar Extraordinaire EIGHT PROVIDER Active VA MEDICAL CENTER ALBANY NY 12180 MATTHEW M KING Active
Procedures
Type Date Code Description Location Substance Method Position Site Status Source
Procedure Date: Oct 13, 2010
84295 (CPT-4) Sodium; serum, plasma or whole blood (CPT-4 84295) Completed NANCY ANTHRACITE
Procedure Date: Oct 5, 2010
99213 (CPT-4) INTERMEDIATE (15min) Completed MATTHEW M KING
Encounters
Type Date Location Status Practitioner Description Indications Source
Sodium; serum, plasma or whole blood (CPT-4 84295) Sodium; serum, plasma or whole blood (CPT-4 84295) NANCY ANTHRACITE
***ESTABLISHED PATIENT*** INTERMEDIATE (15min) ***ESTABLISHED PATIENT*** INTERMEDIATE (15min) MATTHEW M KING
Sodium; serum, plasma or whole blood (CPT-4 84295)